Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure
The design and synthesis of new pyrido[3,4-g]quinazoline derivatives is described as well as their protein kinase inhibitory potencies towardfive CMGC family members (CDK5, CK1, GSK3, CLK1 and DYRK1A). The interest for this original tricyclic heteroaromatic scaffold as modulators of CLK1/ DYRK1A act...
Main Authors: | Knapp, S, Chaikuad, A, Esvan, Y, Zeinyeh, W, Boibessot, T, Nauton, L, Thery, V, Loaec, N, Meijer, L, Anizon, F, Giraud, F, Moreau, P |
---|---|
Format: | Journal article |
Published: |
Elsevier
2016
|
Similar Items
-
Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure
by: Esvan, Y, et al.
Published: (2016) -
Synthesis and Kinase Inhibitory Potencies of Pyrazolo[3,4-<i>g</i>]isoquinolines
by: Mathilde Defois, et al.
Published: (2022-08-01) -
The Nitro Group Reshapes the Effects of Pyrido[3,4-<i>g</i>]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells
by: Sophia S. Borisevich, et al.
Published: (2024-02-01) -
CMGC Kinases in Health and Cancer
by: Iftekhar Chowdhury, et al.
Published: (2023-07-01) -
Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.
by: Akué-Gédu, R, et al.
Published: (2009)